Delivery Order SPE2DR25D1053-SPE2DR26FV829
- Not listed
- The Defense Logistics Agency awarded a $4,586.00 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used for heart failure and hypertension treatment,...
- The Defense Logistics Agency awarded a $9,283.93 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 25, 2025, with completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Carvedilol is a beta-blocker used to treat heart failure and hypertension, representing routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.82 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $1,366.76. The award, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a non-set-aside competitive award to the vendor's Corporate Office located in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication used primarily for managing hypertension and heart...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,334.92 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units). This firm fixed-price, non-set-aside contract was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 28, 2026, for Carvedilol ER 40 mg capsules in quantities of 30 units. The contract carries a ceiling value of $8,735.99 and is scheduled for completion by January 29, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) valued at $3,322.66. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the primary pharmaceutical distributor. The order is scheduled for completion by September 19, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,111.50 for Carvedilol ER 40 mg capsules (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on December 2, 2025, with a ceiling value of $1,413.96 and an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $1,932.48. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Carvedilol is a...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV829Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,968.71 to Amerisourcebergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker used to treat cardiovascular conditions including hypertension and heart failure, representing a critical pharmaceutical supply for military healthcare systems. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical commodities to support military healthcare programs worldwide. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing essential medical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Troop Support is planning to transition to next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards anticipated.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 1/27/26 |